We enjoyed our first joint webinar with PharmaMedic and Triducive of 2022. Our guest speakers, Dr Malcolm Barratt-Johnson (PharmaMedic) and Tim Warren (Triducive) joined Nick Williams (Triducive) for a discussion and interactive Q&A on the evolving and increasingly strategic role of medical affairs within pharma and life sciences businesses. Read on for the key takeaways.
In the UK, we now seem to be moving into a new phase of pandemic management, with the government aiming to” transition to managing COVID-19 like other respiratory illnesses”. In their recent March 2022 statement, the government attributes this evolution in approach to vaccines and treatments. In this short article, we overview the current role of antivirals and monoclonal antibodies and look ahead to future developments in our attempt to manage the day-to day risks of living with COVID-19.
Join Triducive and PharmaMedic for an interactive webinar on Thursday 28th April at 8.00AM. Keynote speakers Dr Malcolm Barratt-Johnson and Tim Warren will be discussing the strategic role of medical affairs in Pharma and the potential role of Delphi based studies for strategic impact. Find out more.
Non-Executive Directors play an integral role for any organisation, not least within the life science space where leadership often needs to draw on a broad range of strategic and tactical expertise to drive the business forward. In this short Q&A article, we interview PharmaMedic Managing Director Dr Malcolm Barratt-Johnson about the value that a pharmaceutical physician delivers in the role of NED.
We enjoyed our first virtual breakfast briefing of 2022, with a new lively panel discussion format. Our guest panelists, Dr Lucy Cook (PharmaMedic consultant and Director of Wiltshire Pharma), Mr Guy Francis (UK Marketing Director, Amarin UK) and Mr Andy Wise (Managing Pharma Consultant, Blue Pelican) joined Dr Malcolm Barratt-Johnson to discuss key themes set to shape medical affairs in 2022. Read on for a summary of key takeaways and to access our recording of the event.
The JP Morgan Healthcare conference is the flagship global investment focused event and marked its 40th year in January 2022 with a virtual event. Typically, the hot topics from JP Morgan set the tone for the life science community for the rest of the year. In this short round up, we will summarise some of the key themes and ‘mood music’ emerging from the conference that have been reported by the industry press.
PharmaMedic is delighted to announce our next virtual breakfast briefing on Thursday 24th February 2022 at 8 am. For this virtual session, we invite you to join experts Dr Malcolm Barratt-Johnson, Mr Guy Francis, Dr Lucy Cook and Mr Andrew Wise for a lively panel discussion tackling the key industry and medical affairs trends we expect to emerge in 2022 and how we can best adapt to succeed. Learn more about the agenda and register here.
Over the last two years, as a whole society and within the pharmaceutical community specifically, we have been forced to adapt and change at an unprecedented scale and speed. While we certainly hope that 2022 will represent less disruption and more recovery, we expect a continued climate of change. In this article Dr Malcolm Barratt-Johnson outlines some of the key trends set to shape the industry in 2022.
Many thanks to LBIC and Lucy Garnsworthy for featuring PharmaMedic’s insights on recent UK government initiatives to support pharma and medicaldevices regulatory innovation in its winter newsletter. The article features on page 6 of the newsletter.
The petrol shortages earlier this quarter disrupted the country and impacted supply and distribution channels across sectors. In this new article we discuss issues affecting our vital UK pharmaceutical supply chain and the ways in which organisations can build resilience.
